In addition, in lung cancer cell lines, mutant TP53 induces the expression of micro-RNA-128-2, which inhibits apoptosis by downregulating the expression of the repressor E2F5, conferring resistance to CDDP (41). Here, E2F5 is linked to lung carcinoma.